JP2013127762A - Management system for collection/operation of regenerative medicine technology - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a management system for collecting and operating the technology of a regenerative medicine.SOLUTION: In the management system of collection and operation of regenerative medicine technology corresponding to information relating to the collection/supply/treatment/costs of the regenerative medicine technology for collecting the technology of the regenerative medicine from the developer of a medical research laboratory/medical equipment manufacturer or the like to supply the technology of the regenerative medicine to the operator of a hospital/clinic or the like, and for enabling the operator who has the technology of the regenerative medicine to treat a patient or the like in order to enlighten and spread the regenerative medicine, a manager recruits the developer and the operator to settle a business cooperation contract with the developer and the operator as a business undertaker, and recruits the patient to settle a medical cooperation contract with the patient or the operator, and recruits the developer to collect the technology of the regenerative medicine, and manages a process of recruiting the operator to supply the technology of the regenerative medicine from the developer to the operator, a process of recruiting the patient or the like to introduce the patient or the like to the operator, and to enable the patient to receive the treatment of the regenerative medicine, and a process of clarifying costs due to those processes by installing a management center.

Description

  The present invention relates to a system for managing a business that collects and implements regenerative medical technology or a business that supports the implementation.

  The challenges of modern life are treating adults, intractable diseases, etc., sick people, physically handicapped people, radiation survivors, correcting those suffering from aging, blemishes, wrinkles, obesity, etc. By treating pets (including pets, patients, etc.), not only human health and beauty, but also maintaining and restoring pet health.

  In order to maintain, recover, and enhance the health and beauty of patients and the like, optimal medical technology is required, and at present, this is being realized as regenerative medicine using stem cells. This is used clinically depending on the type of stem cell. One is an ES cell (embryonic stem cell), two are IPS cells (artificial pluripotent stem cells), and three are somatic stem cells, particularly mesenchymal stem cells.

  When using adipose tissue-derived mesenchymal stem cells (hereinafter referred to as stem cells), there are no problems such as teratoma formation, tumorigenesis or immune rejection compared to ES cells and IPS, and complete serum-free culture. Therefore, it is safe and high quality because it utilizes cell culture technology that does not differentiate cells and has an epoch-making speed. Therefore, this stem cell has now become a medical technique suitable for clinical use.

  From the viewpoint of humanitarian assistance (compassionate use), this regenerative medicine technology is considered to be an urgent and important issue for radiation survivors from the Fukushima nuclear power plant and patients suffering from intractable diseases such as cancer. There are currently 600 successful cases of regenerative medicine. However, this regenerative medicine technique is not necessarily in general clinical use not only in patients but also in hospitals and clinics (referred to as hospitals).

  The reasons for this are as follows. One is that the patient or the like has not been provided with information on where to go to receive the optimal treatment for regenerative medicine. Second, hospitals and the like have not been provided with the technology on how to use the technology related to regenerative medicine treatment clinically.

Then, at present, there is an urgent need for activities to raise awareness and dissemination to the general public, including patients and hospitals, about the possibility of clinical use of this regenerative medicine technology. For this purpose, the latest technology related to regenerative medicine is collected from medical laboratories and medical technology manufacturers, and this technology is provided to hospitals, etc., and the hospitals treat patients etc. using this technology. It is necessary to prepare a system.

  However, patients who need to receive regenerative medical treatment can be classified into three categories from the viewpoint of payment of treatment costs. Patients in Japan and abroad who can afford treatment costs, patients who are reluctant to pay for treatment, etc., patients who are unable to pay for treatment due to difficulties in living. Therefore, support for implementation corresponding to these persons should be considered.

  The following support can be considered for patients with sufficient funds. The first is travel-related medical treatment (medical tourism), where you can enjoy medical trips and receive regenerative medicine while enjoying a sightseeing trip. The other is stem cell deposit (banking), and in the event of a future accident, disease or aging, regenerative treatment is performed with the stem cells collected, cultured and stored.

  The following support can be considered for patients with insufficient funds. One is a bank loan, which receives a loan from the bank, pays the treatment expenses in a lump, and then repays the bank in several steps. The other is the application of insurance, in which regenerative medical insurance is pre-subscribed, and the insurance money is used to pay for the treatment costs while continuing to pay the insurance premiums.

  From the viewpoint of humanitarian assistance, social support can be considered for patients who do not have funds or for those exposed to radiation exposure from the Fukushima nuclear power plant. Taking Bellmark's sponsorship system as an example, when selling products and providing services, companies donate a certain percentage of sales, and consumers collect points and donate.

  Even if there are various implementation support methods for patients who need to receive regenerative medical treatment, they are not used by patients, hospitals, etc., as with regenerative medical technology itself. This is because hospitals and the like do not have a system for making these methods known to patients, and therefore patients and the like have no way of knowing these information.

Technical literature

  nothing special.

  The problems to be solved by the present invention are as follows.

  First, people suffering from various diseases such as intractable diseases such as atopy, polio, cerebral palsy, leukemia, etc., adult diseases such as hypertension, kidney disease, diabetes, cancer, etc. By treating Noh survivors, correcting those suffering from deterioration of the body such as aging, blemishes / wrinkles, small breasts / obesity, thinning hair, and treating pets similar to their families, In order to maintain, restore, and promote beauty, regenerative medicine technology is required especially to rescue radiation survivors and patients with intractable diseases caused by the Fukushima nuclear power plant.

  However, even though the latest technology of regenerative medicine has been developed one after another, even if 600 cases can be counted now, hospitals that should use this clinically do not know the information of this technology or use the technology to use this technology. If they do not have this, they cannot prevent or treat patients or the like, so a hospital or the like needs a means of knowing information on the latest regenerative medical technology.

  In addition, even if the latest technology of regenerative medicine is developed one after another, and even if hospitals etc. are using this technology clinically, if patients do not know information about the existence of such hospitals, Since prevention and treatment cannot be received, a means for patients to know information about the existence of a hospital using the latest medical care is required.

  Then, it is necessary for hospitals to know and implement information related to the latest technology in regenerative medicine, and to know information related to the existence of hospitals that have this technology and to receive treatment. is there. Regenerative medicine technology is an urgent and important issue for patients, especially those exposed to radiation from Fukushima and those with intractable diseases.

  Furthermore, patients and the like who need to receive regenerative medicine can be classified into various types from the viewpoint of payment of treatment costs, so it is necessary to support implementation corresponding to each type. For patients who have sufficient funds, travel-related treatment or stem cell deposit (banking), for patients who have difficulty in lump sum payment, bank loans or insurance, for patients who are in need of funds Therefore, it is necessary to consider the social burden of treatment costs.

  However, even if there are various ways of providing support for patients who need regenerative medicine, hospitals etc., as well as regenerative medicine technology itself, make these methods known to patients. As such, patients need to be provided with information on these methods and their effective use.

  Means to be solved by the present invention are as follows.

  First of all, not only those who treat various diseases such as adult diseases and intractable diseases, persons with physical disabilities, radiation survivors, and those who suffer from physical deterioration such as aging, obesity, thinning hair, spots, wrinkles, etc. Collect and implement regenerative medical technologies for the purpose of treating similar pet diseases and maintaining and restoring the health and beauty of human and pet patients (4), and at the same time cost It is a management system for the collection and implementation of regenerative medicine technology, which was established to clarify and popularize regenerative medicine.

  In this system, the operator (1) recruits developers (2) such as medical laboratories and medical technology manufacturers, and implementers (3) such as hospitals and clinics. By concluding a business cooperation contract between the two, and recruiting patients, etc. (4), and concluding a medical cooperation contract with these patients, etc. (4) and the practitioner (3), the management center ( 10) installing regenerative medical technology from developer (2) to practitioner (3), introducing practitioner (3) to patient (4) and receiving treatment (8) , To manage the process of clarifying the costs arising from these processes.

  This system allows operators (2), (3), patients, etc. (4) to input, send, receive, and display information related to collection (5), provision (6), introduction (7), treatment (8) of regenerative medicine technology. The terminal device with the function to receive, and the management center (10) accepts and registers information related to the collection (5), provision (6), introduction (7), treatment (8) of regenerative medical technology and the costs resulting from these -It is comprised from the central processing unit (11) which has the function to store / display and transmit to the terminal devices of the business operators (2) (3) and patients (4).

  Between the central processing unit (11) of the management center (10) and the operators (2) (3), the terminal devices of patients (4), etc. constituting the system, the developer (2) and the implementer (3 ) Collection (5) and provision of regenerative medicine technology by recruitment (5), introduction of regenerative medicine (7) and treatment (8) of the implementer (3) by recruitment of patients etc. (4), and these The transmission / reception / display of information related to the expenses caused by is performed through the Internet (9).

  The central processing unit (11) of the management center (10) comprises communication means (12), storage means (13), management means (14), search means (15), storage means (16) and the like. Collection (5), provision (6), introduction (7) of regenerative medical technology sent from the terminal devices of the business operators (2) (3) and patients (4) via the Internet (9) )-Corresponds to information on treatment (8) and costs.

  In addition to this, the operator (1), as the management center (10), concluded a business cooperation contract for stem cell deposit (banking) with the implementer (3), and accidents, illnesses, and aging of future patients, etc. (4) In preparation for regenerative medicine by the future, through the recruitment of future patients (4), introduce the future patients (4) to the implementer (3) (7) and collect, culture and store stem cells, It is also possible to manage the process of clarifying the costs resulting from this, support (22) the implementation of regenerative medicine and disseminate it.

  As the management center (10), the operator (1) concludes a business cooperation contract for travel-related medical treatment (medical tourism) that combines tourism and regenerative treatment with the travel agency (19) and the practitioner (3). Through the recruitment of etc. (4), manage the process of introducing patients etc. (4) to travel agencies (19) and implementers (3) and receiving travel-related medical care, and clarifying the costs resulting from this, Support (22) the implementation of regenerative medicine and dissemination.

  The operator (1), as the management center (10), has entered into a business cooperation contract regarding bank loan or insurance application in order to facilitate the payment of regenerative medical treatment expenses by patients etc. (4) (19) Or the process of signing with an insurance company (19) and introducing the patient (4) to the bank (19) or the insurance company (19) through recruitment of the patient (4) and receiving the loan or insurance of the bank It is also possible to manage the process of clarifying the costs resulting from these, support (22) the implementation of regenerative medicine and disseminate it.

  The operator (1), as a management center (10), has signed a sponsorship agreement on social support for treatment costs in order to eliminate the difficulty in paying treatment costs for regenerative medicine by patients (4). 19), through the recruitment of the company (19), manage and regenerate the process of allocating the support money collected from the company (19) to the treatment expenses of patients (4), and clarifying the support money related to this It can support (22) and disseminate medical practice.

  The effects of the present invention are as follows.

  First, the present invention solves not only human health and beauty but also pet health by regenerative medicine. In other words, regenerative medicine is applied to intractable diseases such as atopy, polio, cerebral palsy, and leukemia, sick persons suffering from adult diseases such as kidney disease, hypertension, diabetes, and cancer, physically handicapped persons such as half-body, sports accidents, radiation It is possible to treat A-bomb survivors, to correct those suffering from deterioration of the body such as aging, obesity, small breasts, spots and wrinkles, and to treat pet diseases similar to those of families.

  Next, the present invention aims at enlightening and spreading the possibility of regenerative medicine technology through collection and implementation of regenerative medicine technology. In other words, since anyone has the opportunity to know information on regenerative medicine, it can be determined which hospital / clinic, etc., can receive regenerative medicine.

  Furthermore, the present invention provides an opportunity to provide patients and the like (4) with the latest technology related to regenerative medicine by continuing to collect regenerative medicine techniques. In other words, any hospital / clinic implementer (3) introduces the latest technology related to regenerative treatment developed by a developer (2) such as a medical research institute or medical technology manufacturer, and uses the regenerative treatment technology clinically. can do.

  Finally, the present invention can provide various support for patients (4) using regenerative medicine. In other words, patients (4) who have sufficient funds can receive regenerative medical treatment while enjoying travel, or provide stem cell deposit opportunities for future regenerative medical treatment, and pay for lump sum payments. (4) is not a lump sum payment for treatment costs, but bank loans and insurance are allowed, and patients (4) who are in need of funds have a way to socially pay treatment costs. Can be given.

  FIG. 1 is a diagram showing the configuration of the system of the present invention.   FIG. 2 is a diagram showing the process of collecting and implementing regenerative medical technology in the system of the present invention.   FIG. 3 is a diagram showing a process for supporting the implementation of the regenerative medical technique added to the system of the present invention.

  The form for carrying out the present invention is as follows.

  The present invention is a management system for collecting, implementing, and supporting regenerative medical technology.

  The present invention relates to intractable diseases such as atopy, polio, cerebral palsy, and leukemia, adult diseases such as diabetes, kidney disease, hypertension, and cancer, persons suffering from various diseases, persons with physical disabilities such as half-body injuries, persons caused by sports accidents To treat people exposed to radiation, to correct those suffering from deterioration of the body such as aging, obesity, small breasts, blemishes, thinning hair, etc. It is a system that uses regenerative medicine for the purpose of maintaining and restoring the health of pets as well as beauty and beauty.

  In the present invention, the operator (1) concludes a business cooperation contract through the recruitment of the developer (2) and the implementer (3), and through the recruitment of the patient (4), the patient (4) By signing medical cooperation with the practitioner (3), implementation supporters such as the practitioner (3), travel agencies (19), banks (19), insurance companies (19), general companies (19), etc. (development) Collecting the latest technology related to regenerative medicine (5), providing (6), and introducing (7) A system for managing information that provides treatment (8) or supports implementation (20) and clarifies the costs resulting from these.

  As the management center (2), the operator (1) manages the process of collecting the latest technology related to regenerative medicine from the developer and providing it to the practitioner (3), and the patient (4) Manage the process of introducing (7) to the person (3) and receiving the latest treatment (8), further managing the process of supporting the implementation of regenerative medicine by the implementation supporter (19), and from these Manage the process of clarifying the costs incurred.

  This system provides information on the process of collecting (5), providing (6), introducing (7), treating (8) and supporting (20) regenerative medicine technology and the process of clarifying the costs resulting from these. (2) (3) (19), a terminal device having a function of inputting, transmitting, receiving, and displaying this information (4), and a management center receiving, registering, storing, and displaying this information, and The central processing unit (11) has a function of transmitting to the terminal devices of the business operators (2), (3), (19), patients, etc. (4).

  Recruitment of developers (2) and implementers (3) between the terminal devices of the operators (2) (3) (19) and the central processing unit (11) of the management center (10) constituting this system Collection (5) and provision of regenerative medicine by (6), introduction of regenerative medicine (7) and treatment (8) of the implementer (3) by recruitment of patients etc. (4), and implementation supporters ( The support of the implementation according to 19) and the transmission / reception / display of information on the costs resulting from these are performed through the Internet (9).

  The central processing unit (11) of the management center (10) comprises communication means (12), storage means (13), management means (14), search means (15), storage means (16) and the like. Regenerative medical technology collection (5), provision (6), sent from the terminal devices of business operators (2) (3) (19) and patients (4) via the Internet (9) It corresponds to information on introduction (7), treatment (8), support (20) and costs.

  This system consists of three processes. One is the process of collecting and granting the latest technology related to regenerative medicine, the second is the process of referral and treatment to patients by regenerative medicine, and the third is the support for the implementation of regenerative medicine for patients etc. It is a process to do.

  The first is the collection and provision of the latest technology related to regenerative medicine. The operator (1) collects the regenerative medicine technology by concluding a business cooperation contract through the recruitment of the developer (2) who has the regenerative medicine technology, and the operator (3) who needs this technology. This is a process of providing regenerative medical technology from the developer (2) to the practitioner (3) by recruiting.

  The first is recruitment of developers (2). The operator (1) registers and stores information related to recruitment of regenerative medical technology in the central processing unit (11) of the management center (10), and then discloses it on the bulletin board on the Internet (9), and the developer (2) Wanted. In response to this, when considering the conclusion of the business cooperation contract with the operator (1), the developer (2) obtains information regarding the conclusion of the contract and transmits the information from the terminal device to the central processing unit (11). .

  Then, the operator (1) registers and stores information related to the business cooperation contract with the developer (2) in the central processing unit (11) of the management center (10), and then stores it in the terminal device of the developer (2). Send and ask for acceptance of contract conclusion. The developer (2) collaborates with the operator (1). Therefore, when the developer (2) decides to participate in the system, information regarding the consent is input to the terminal device and transmitted to the central processing unit (11).

  Next, it is recruitment of the implementer (3). The operator (1) registers and stores information related to recruitment of the practitioner (3) who needs regenerative medical technology in the central processing unit (11) of the management center (10) and then puts it on the bulletin board on the Internet (9). Disclosure and recruiters (3). Accordingly, when considering the conclusion of the business cooperation contract with the operator (1), the implementer (3) obtains this information and transmits it from the terminal device to the central processing unit (11).

  Then, the operator (1) registers and stores information related to the business alliance agreement with the implementer (3) in the central processing unit (11) of the management center (10), and then stores it in the terminal device of the implementer (3). Send and ask for acceptance of contract conclusion. The implementer (3) cooperates with the operator (1). Therefore, when it decides to participate in this system, information regarding the consent is input to the terminal device and transmitted to the central processing unit (11).

  Furthermore, the company is providing regenerative medical technology. The operator (1) registers and stores information on the number and contents of the implementers (3) in the central processing unit (11) of the management center (10), and transmits the information to the terminal device of the developer (2). The developer (2) inputs this information to the terminal device, inputs information for providing regenerative medical technology to the practitioner (3), and transmits the information to the central processing unit (11).

  Then, the operator (1) registers and stores information related to regenerative medical technology in the central processing unit (11), and transmits it to the terminal device of the practitioner (3). The developer (2) transmits / receives to / from the terminal device of the practitioner (3) via the central processing unit (11) from the terminal device, responds to the questions of the practitioner (3), and the facility of the practitioner (3) In addition to providing doctors and technicians, we will give practical guidance and also decide to provide pharmaceuticals.

  Finally, the costs incurred from the regenerative medical technology collection process are the technical guidance fee and culture fee charged by the developer (2) to the implementer (3), and the operator (1) and the developer (2) and This is an operation fee charged to the implementer (3). The operator (1) has the central processing unit (11) of the management center (10) and relates to the number of developers (2) and implementers (3), as well as the number and content of technical guidance of the developer (2). Information is registered / stored in the central processing unit (11) and transmitted to the terminal devices of the business operators (2) and (3).

  The second is treatment of patients (4) by regenerative medicine technology. The operator (1) recruits patients (4) who need regenerative medicine and concludes a medical cooperation contract with the practitioner (3) or patients (4), thereby implementing the practitioner (3 ) Is a process of implementing regenerative medical technology for patients (4).

  First, recruitment of patients (4). The operator (1) registers and stores information related to regenerative medicine treatment in the central processing unit (11) of the management center (10), and then discloses this information on a bulletin board on the Internet (9), and the patient (4 ). In response to this, the patient (4) obtains information related to the regenerative medicine and the practitioner (3) when considering treatment related to the regenerative medicine, and transmits the information from the terminal device to the central processing unit (11).

  Then, the operator (1) registers and stores information related to the medical cooperation contract in the central processing unit (11), and then transmits the information to the terminal device of the patient (4) and asks for approval or disapproval of the contract conclusion. The patient or the like (4) cooperates in medical care, and therefore, when it decides to participate in this system, information regarding this consent is input to the terminal device and transmitted to the central processing unit (11).

  Next, treatment of patients (4). The operator (1) registers and stores information on the number of patients, etc. (4) and information on diseases, etc. in the central processing unit (11) of the management center (10), and the operator (3) and developer (2), respectively. ) To the terminal device. The patient or the like (4) transmits and receives from the terminal device to the terminal device of the practitioner (3) via the central processing unit (11), receives guidance or consultation from the practitioner (3) about regenerative medicine, Can receive actual treatment.

  Finally, the costs incurred from the regenerative medical treatment process are the culture and treatment costs that the practitioner (3) can charge to the patients etc. (4), and the operator (1) the patients etc. (4) and This is an operating fee that can be charged to the implementer (3). The operator (1) registers and stores in the central processing unit (11) information on the number of patients, etc. (4) and the number of practitioners (3), and the number and contents of treatments of the practitioner (3). This information is transmitted to the terminal devices of the business operators (2) (3) and patients (4).

  The third is support for implementation of patients (4). This is in accordance with the type of patient (4) requiring regenerative medicine. Based on the ease or difficulty of paying treatment costs, this is a process of classifying patients who have sufficient funds, patients who are reluctant to collect payments, patients who are reluctant to pay, and providing support corresponding to each. .

  One is stem cell depositing (banking) in which stem cells are collected, cultured and stored. In preparation for regenerative medicine due to future accidents, illnesses, and aging for patients with sufficient funds in Japan and overseas, the organization will deposit stem cells and support the implementation of regenerative medicine. This is because normal stem cell therapy requires a minimum of 40 days for prior aptitude testing, stem cell collection, culture, and the like.

  The practitioner (3) inputs information related to stem cell deposit to the terminal device and transmits it to the central processing unit (11). The operator (3) registers and stores this information in the central processing unit (11), discloses it on the bulletin board on the Internet (9), and recruits patients etc. (4). In response to this, the future patient or the like (4) obtains this information and transmits it from the terminal device to the central processing unit (11) when considering information on stem cell deposit.

  Then, the operator (1) registers and stores information related to the stem cell deposit contract in the central processing unit (11), and then transmits it to the terminal device of the future patient or the like (4) to ask for approval or disapproval of the contract conclusion. When a future patient or the like (4) concludes a deposit agreement, this information is input to the terminal device and transmitted to the central processing unit (11). The practitioner (3) collects, cultures and stores stem cells from the future patient (4).

  Expenses incurred from stem cell deposits include culture costs and storage charges charged to the future patient (4) by the implementer (3), and the future patients (4) and the implementer (3) ). The operator (1) registers / registers the number of future patients, etc. (4) and the number of practitioners (3), the number of times the practitioner (3) is stored, and information on the contents with the central processing unit (11). The information is stored and transmitted to the terminal devices of the business operators (2) and (3).

  The second is travel tourism (medical tourism) that combines tourism and regenerative medicine. Implementing regenerative medicine for patients (4) who have sufficient funds in Japan and abroad by providing opportunities for patients (4) to receive regenerative medicine, including a medical checkup, while enjoying a sightseeing trip Is to promote.

  The travel agency (19) inputs information related to travel-related regenerative medicine to the terminal device and transmits it to the central processing unit (11) of the management center (10). The operator (1) registers and stores this information in the central processing unit (11) and discloses it on the bulletin board on the Internet (9). In response to this, the patient or the like (4) obtains this information and transmits it from the terminal device to the central processing unit (11) when considering travel-related regenerative medicine.

  Then, the operator (1) registers and stores information related to the travel-related regenerative medicine contract in the central processing unit (11), and then transmits it to the terminal device of the patient (4) and asks for approval or disapproval of the contract conclusion. When the patient (4) concludes a contract, this information is input to the terminal device and transmitted to the central processing unit (11). The patient (4) receives medical treatment along with the trip with the support of the travel agency (19) and the practitioner (3).

  Expenses incurred from travel-related treatment are the treatment and culture costs charged by the implementer (3) to the patient etc. (4), the travel fee charged by the travel agency (19) to the patient etc. (4), and the operator ( 1) is an operation fee charged to the implementer (3), the travel agency (19) and the patient (4). The operator (1) registers in the central processing unit (11) information on the number of the practitioner (3), the travel agency (19), the number of patients, etc. (4), and the number of treatments and details of the practitioner (3). Store and send this information to the terminal devices of the operators (2) (3) (19).

  The third is the application of bank loans and insurance to patients (4) in order to facilitate the payment of treatment costs for regenerative medicine. For patients (4) who are hesitant to pay for treatment expenses (4), with the support of the bank and insurance company, pay the treatment expenses with funds borrowed from the bank (19) or insurance money from the insurance company (19) This will promote the implementation of regenerative treatment.

  The bank and the insurance company transmit information on the financing of treatment costs and the application of insurance from the terminal device to the central processing unit (11). The operator (1) registers and stores this information in the central processing unit (11), discloses this information on a bulletin board on the Internet (9), and recruits patients etc. (4). In response to this, the patient (4) obtains this information and transmits it from the terminal device to the central processing unit (11) when considering bank financing or insurance.

  Then, the operator (1) registers and stores information related to the bank loan or insurance application contract in the central processing unit (11), and then transmits it to the terminal device of the patient (4) to accept or reject the contract conclusion. Ask for. When the patient (4) concludes this contract, this information is input to the terminal device and transmitted to the central processing unit (11). The patient (4) receives a loan or insurance payment with the support of the bank (19) or the insurance company (19).

  The cost generated from the loan or insurance is an operation fee charged by the operator (1) to the patient (4), the bank (19) and the insurance company (19). Operator (1) centrally computes information on the number of patients, etc. (4) who used loans or insurance, the number of banks (19) and insurance companies (19), and the number and contents of loans or insurance. It is registered and stored in the device (11), and this information is transmitted to the terminal devices of the business operators (2) (3) (19).

  Fourthly, in order to eliminate the difficulty in paying the regenerative medicine treatment cost, the support for the treatment cost for the patient (4) is provided. This is because of the humanitarian support of patients, etc. who have difficulty in living and are unable to pay for the treatment costs (4), especially for the survivors of the Fukushima nuclear power plant that are becoming more serious recently. A large burden and promote the implementation of regenerative medicine.

  The operator registers and stores information on social support for treatment costs in the central processing unit (11), and then discloses it on the bulletin board on the Internet (9), and the company (19), especially publishers, broadcasting stations, power And call for support from nuclear power related manufacturers, life insurance companies, banks and securities companies. In response, the company (19) obtains this information and transmits it from the terminal device to the central processing unit (11) when considering this support.

  Then, the operator (1) registers and stores information on the sponsorship contract for social support for treatment costs in the central processing unit (11), and then transmits the information to the terminal device of each company (19). Ask for or against. When the company (19) decides to conclude a sponsorship contract for social support, this information is input to the terminal device and transmitted to the central processing unit (11).

  The operator (1) registers and stores information on the name and number of companies (19) that provide social support in the central processing unit (11), starts each company (19), patients, etc. (4) and The information is transmitted to the terminal devices of the business operators (2) and (3), and the name of the company that makes a social contribution is announced on the bulletin board on the Internet (9).

  The company (19), for example, uses a sponsorship mark, and contributes a certain amount according to the ratio of sales and provision of goods and services and the ratio of points accumulated by consumers. The company (19) inputs information related to the donation to the terminal device and transmits it to the central processing unit (9). The operator (1) registers and stores information received from the company (19) in the central processing unit (11), and stores this information in the terminals of the operators (2) (3) (19) and the patients (4). Send to device.

  Expenses arising from the social burden of treatment costs are sponsorship money from the sales of the company (19) and sponsorship money from consumers. The operator (1) registers and stores information on the number of companies and consumers and the company name in the central processing unit (11), and stores this information not only in the company (19) but also in the company (2) ( 3) Also transmit to the terminal devices of (19) and patients etc. (4).

  Examples of the present invention are as follows.

  First, as shown in FIG. 1 and FIG. 2, the operator (1) collects information related to the delivery of regenerative medicine in order to recruit developers (2) and practitioners (3). After registering and storing in 11), this information is posted on a bulletin board on the Internet (9). In response to this, when the developer (2) and the implementer (3) who are interested in this information make an inquiry to the central processing unit (11) from the terminal device, the operator (1) concludes a business cooperation contract. Is registered and stored in the central processing unit (11) and transmitted to the terminal devices of the developer (2) and the implementer (3). When the developer (2) and the implementer (3) conclude this contract, information regarding the consent is input to the terminal device and transmitted to the central processing unit (11). The developer (2) sends and receives information from the terminal device to the terminal device of the operator (3) via the central processing unit (11), and provides information related to regenerative medical technology (17).

  Next, as shown in FIGS. 1 and 2, the operator (1) registers and stores information related to regenerative medicine treatment guidance in the central processing unit (11) in order to recruit patients and the like (4). Later, this information will be posted on a bulletin board on the Internet (9). In response to this, when the patient (4) who is interested in this information makes an inquiry to the central processing unit (11) from the terminal device, the operator (1) sends information on the conclusion of the medical cooperation contract to the central processing unit. It is registered and stored in (11), and is transmitted to the terminal device of the patient etc. (4). When the patient or the like (4) concludes this contract, information regarding the consent is input to the terminal device and transmitted to the central processing unit (11). The operator (1) registers and stores information regarding the number of patients and the like (4) and the disease in the central processing unit (11), and transmits the information to the terminal devices of the implementer (3) and the developer (2). The patient or the like (4) transmits / receives to / from the terminal device of the practitioner (3) via the central processing unit (11) from the terminal device, receives guidance or consultation from the practitioner (3) about regenerative medicine, and Can receive actual treatment (18).

  Furthermore, as described in FIG. 3, the operator (1), through the management center (10), by signing a business cooperation contract related to depositing (banking) for collecting and storing stem cells with the operator (3), Through recruitment of future patients, etc. (4), introduce the future patients, etc. (4) to the implementer (3) (7) and receive the deposit of stem cells, and clarify the costs resulting from this Patients, etc. by managing the process or by signing a business cooperation contract with the traveler (19) and the practitioner (3) for travel-related medical treatment (medical tourism) that combines tourism and regenerative treatment Through the recruitment of (4), the patient (4) is introduced to the traveler (19) and the practitioner (3) to receive the travel-related medical care, and the process resulting therefrom is managed.

  Further, as shown in FIG. 3, the operator (1) concludes a business cooperation contract with the bank (19) or the insurance company (19) through the management center (10) regarding the bank loan or insurance application. Through the recruitment of patients, etc. (4) through the process of introducing patients, etc. (4) to the bank (19) or insurance company (19) and applying for bank loans or insurance, and costs resulting therefrom Manage the process of clarifying.

  Further, as shown in FIG. 3, the operator (1), through the management center (10), makes a sponsorship agreement for socially supporting patients (4) who are in need of regenerative medicine treatment costs (4). 19) The process of collecting the sponsorship money of the company (19) through the recruitment of the company (19) and allocating it to the treatment expenses for the patients (4) and the costs resulting from this are clarified Manage.

DESCRIPTION OF SYMBOLS 1 Operator 2 Developer 3 Implementer 4 Patients etc. 5 Regenerative medical technology collection information 6 Regenerative medical technology grant information 7 Regenerative medical introduction information 8 Regenerative medical implementation information 9 Internet 10 Management center 11 Central processing unit 12 Communication means 13 Storage means 14 Management means 15 Search means 16 Storage means 17 Regenerative medicine technology provision 18 Regenerative medicine treatment implementation 19 Implementation supporter 20 Regenerative medicine implementation support information 21 Regenerative medicine implementation support cooperation 22 Regenerative medicine implementation support

Claims (5)

  Regenerative medicine technology is collected from developers such as medical laboratories and medical manufacturers, and is provided to practitioners such as hospitals and clinics. In addition to patients with physical deterioration such as sick persons, disabled persons, radiation survivors, aging, spots, wrinkles, obesity, etc., patients including sick pets are treated and corrected, In order to restore and maintain health and beauty, and to enlighten and disseminate regenerative medicine, the operator recruits developers and implementers, concludes business cooperation agreements with the developers and implementers of businesses, and Recruiting patients, etc., and collecting medical technology for regenerative medicine by recruiting developers by concluding medical cooperation agreements with patients and practitioners, etc. The process of granting to the implementer, recruiting patients, etc. and introducing the patients etc. to the implementer In order to manage the process of receiving regenerative medicine treatment and the process of clarifying the costs resulting from these processes, a management center will be established, and businesses and patients will collect and About the information about the process of providing / treating and the process of clarifying the costs resulting from these, the terminal device having the function of inputting, transmitting / receiving, and displaying such information, and the management center for these information Is configured with a central processing unit that has a function of receiving, registering, storing and displaying, and transmitting to terminal devices such as business operators and patients, and a central processing device of a management device and a terminal device such as business operators and patients. In Japan, collection and provision of regenerative medicine, treatment of regenerative medicine by the practitioner, and transmission / reception / display of information related to costs resulting from these are performed through the Internet. The central processing unit of the management center is equipped with communication means, storage means, management means, search means, storage means, etc., and collects regenerative medical technology transmitted from the terminal devices of business operators and patients via the Internet. A management system for the collection and implementation of regenerative medicine technology, characterized by responding to information on donation, treatment and costs.   In order to prepare for future regenerative medicine by accident, disease, and aging of patients, etc., the operator will conclude a business cooperation contract regarding depositing (banking) for collecting and storing stem cells through the management center. By managing the process of recruiting patients, etc., introducing future patients etc. to the practitioner and receiving the deposit of stem cells, clarifying the costs resulting from this, and supporting the implementation of regenerative medicine, The regenerative medicine technology collection and implementation management system according to claim 1, wherein regenerative medicine is spread.   The operator concludes a business cooperation contract for travel-related medical treatment (medical tourism) that combines tourism and regenerative treatment with the travel agency and the implementer through the management center, and through the recruitment of patients, etc. To support the implementation of regenerative medicine and to promote the use of regenerative medicine by managing the process of introducing travel-related medical care to a person and clarifying the costs resulting from this Management system for collection and implementation of regenerative medicine technology according to item 1.   In order to facilitate the payment of regenerative medicine treatment costs through the management center, the operator concludes a business cooperation agreement with banks or insurance companies regarding the application of bank loans or insurance, and through recruitment of patients, etc. To support the implementation of regenerative medicine by managing the process of introducing a bank or insurance company to receive bank loans or insurance and clarifying the costs resulting from this. The system for collecting and implementing regenerative medical technology according to claim 1, wherein the system is widely used.   The operator, through the management center, concluded a sponsorship agreement on social support for treatment costs with a number of companies in order to rescue patients who have difficulty in paying treatment costs for regenerative medicine. It is characterized by supporting the implementation of regenerative medicine and managing the spread of regenerative medicine by managing the process of collecting the support money for patients and treating the treatment expenses for patients, etc., and the process of clarifying the support money for this. A management system for collecting and implementing regenerative medical technology according to claim 1.

Images